Since chronic treatment with CSP-1103 was found to reduce the brain level of GSK-3β and concomitantly increase the kinase phosphorylated inactive form in a mouse model of AD [33], we investigated one possible rapid activation of the kinase in neuronal cultures exposed to OGD. Here, GSK3B is linked to Alzheimer disease.